What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies?
作者信息
Lamotte Guillaume, Goldstein David S
机构信息
Sleep and Movement Disorders Division, Department of Neurology, Movement Disorders and Autonomic Disorders Clinic, University of Utah, Salt Lake City, UT, 84108, USA.
Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
出版信息
Clin Auton Res. 2022 Apr;32(2):95-98. doi: 10.1007/s10286-022-00859-0. Epub 2022 Feb 24.
Abstract
摘要
相似文献
1
What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies?
Clin Auton Res. 2022 Apr;32(2):95-98. doi: 10.1007/s10286-022-00859-0. Epub 2022 Feb 24.
2
Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
Parkinsonism Relat Disord. 2019 Oct;67:27-33. doi: 10.1016/j.parkreldis.2019.09.014. Epub 2019 Sep 16.
3
Sympathetic neuroimaging.
Handb Clin Neurol. 2013;117:365-70. doi: 10.1016/B978-0-444-53491-0.00029-8.
4
Roles of cardiac sympathetic neuroimaging in autonomic medicine.
Clin Auton Res. 2018 Aug;28(4):397-410. doi: 10.1007/s10286-018-0547-6. Epub 2018 Jul 30.
5
Cardiac sympathetic denervation in Parkinson disease.
Ann Intern Med. 2000 Sep 5;133(5):338-47. doi: 10.7326/0003-4819-133-5-200009050-00009.
6
Diagnostic Efficacy of Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-Synucleinopathies.
Diagnostics (Basel). 2024 Dec 26;15(1):24. doi: 10.3390/diagnostics15010024.
7
Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies.
Ann Clin Transl Neurol. 2020 Dec;7(12):2450-2460. doi: 10.1002/acn3.51243. Epub 2020 Nov 20.
8
Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders.
Eur J Nucl Med Mol Imaging. 2025 Mar 11. doi: 10.1007/s00259-025-07188-0.
9
Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
J Neurol Sci. 2000 Apr 1;175(1):3-12. doi: 10.1016/s0022-510x(00)00279-3.
10
Outcome of epilepsy surgery correlates with sympathetic modulation and neuroimaging of the heart.
J Neurol Sci. 2003 Dec 15;216(1):153-62. doi: 10.1016/j.jns.2003.07.004.
引用本文的文献
1
Value of multi-parameter I-MIBG scintigraphy in the differential diagnosis of Parkinson's disease.
EJNMMI Res. 2025 Jan 29;15(1):7. doi: 10.1186/s13550-025-01197-8.
2
A pathophysiological biomarker combination separates Lewy body from non-Lewy body neurogenic orthostatic hypotension .
Clin Auton Res. 2024 Jun;34(3):329-339. doi: 10.1007/s10286-024-01035-2. Epub 2024 Jun 7.
3
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
Brain Sci. 2023 Oct 18;13(10):1471. doi: 10.3390/brainsci13101471.
4
Cardiac noradrenergic deficiency revealed by 18F-dopamine positron emission tomography identifies preclinical central Lewy body diseases.
J Clin Invest. 2024 Jan 2;134(1):e172460. doi: 10.1172/JCI172460.
5
The grand challenge of autonomic disorders.
Front Neurol. 2022 Nov 1;13:1052137. doi: 10.3389/fneur.2022.1052137. eCollection 2022.
6
[F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?
Clin Auton Res. 2022 Dec;32(6):399-401. doi: 10.1007/s10286-022-00893-y. Epub 2022 Sep 9.
本文引用的文献
1
Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy.
Clin Auton Res. 2022 Apr;32(2):103-114. doi: 10.1007/s10286-022-00853-6. Epub 2022 Feb 11.
2
Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
Brain. 2021 Oct 22;144(9):2732-2744. doi: 10.1093/brain/awab236.
3
Cardiac F-Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA.
Mov Disord Clin Pract. 2021 Mar 23;8(4):582-586. doi: 10.1002/mdc3.13190. eCollection 2021 May.
4
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
J Neurochem. 2021 Jul;158(2):554-568. doi: 10.1111/jnc.15371. Epub 2021 May 21.
5
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
Brain. 2020 Oct 1;143(10):3077-3088. doi: 10.1093/brain/awaa238.
6
Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
Parkinsonism Relat Disord. 2019 Oct;67:27-33. doi: 10.1016/j.parkreldis.2019.09.014. Epub 2019 Sep 16.
7
Cardiac sympathetic denervation predicts PD in at-risk individuals.
Parkinsonism Relat Disord. 2018 Jul;52:90-93. doi: 10.1016/j.parkreldis.2017.10.003. Epub 2017 Oct 5.
8
The heart of PD: Lewy body diseases as neurocardiologic disorders.
Brain Res. 2019 Jan 1;1702:74-84. doi: 10.1016/j.brainres.2017.09.033. Epub 2017 Oct 10.
9
Natural history of pure autonomic failure: A United States prospective cohort.
Ann Neurol. 2017 Feb;81(2):287-297. doi: 10.1002/ana.24877.
10
Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?
Eur J Neurol. 2017 Feb;24(2):349-356. doi: 10.1111/ene.13206. Epub 2016 Nov 26.
Zotero 插件